Exploration of Pregnant Women's Reluctance Toward COVID-19 Vaccination
NCT06968117 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2025-05-13
Summary
This study aims to explore the reasons behind the reluctance of pregnant women to get vaccinated against COVID-19. With the ongoing pandemic, it has become essential to understand the concerns that women have regarding the COVID-19 vaccine, especially during pregnancy. Pregnant women are at a higher risk of severe complications from COVID-19, including premature birth, preeclampsia, and the need for intensive care.The goal of this research is to identify the barriers that prevent pregnant women from getting vaccinated, whether they are based on fears, misconceptions, or a lack of information. By understanding these concerns, healthcare providers can have better conversations with their patients and provide accurate, evidence-based information to help them make informed decisions about their health and the health of their unborn child.Through interviews and visual methods, the study seeks to gather valuable insights into the emotional and psychological aspects of vaccine hesitancy among pregnant women. These findings will help develop a tool to assist healthcare providers in addressing vaccine hesitancy effectively, ensuring that women are given all the necessary information to make the best decision for their health and the well-being of their baby.
Conditions
- Vaccinate Against Covid-19
- Reluctance Pregnant Women's
Sponsors & Collaborators
-
Centre Hospitalier de Gonesse
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-01
- Primary Completion
- 2023-01-01
- Completion
- 2023-01-01
Countries
- France
Study Locations
More Related Trials
-
COVID-19 International Drug Pregnancy Registry
NCT05013632 ·Status: RECRUITING
-
Observational Maternal COVID-19 Vaccination Study
NCT04826640 ·Status: COMPLETED
-
Evaluation of Cardiovascular Risk After Preeclampsia in General Practitioners and Patients
NCT06059937 ·Status: COMPLETED
-
International Registry of Coronavirus (COVID-19) Exposure in Pregnancy
NCT04366986 ·Status: COMPLETED
-
Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID
NCT04387253 ·Status: COMPLETED ·Phase: NA
-
COVID-19 and Pregnancy: Placental and Immunological Impacts
NCT04726111 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Ambivalence Regarding Prenatal Testing
NCT00342069 ·Status: COMPLETED
-
Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum: Evaluation of Clinical Practices in Five Maternity Hospitals in Île-de-France
NCT06841029 ·Status: COMPLETED
-
The Pregnancy & Early Life Study
NCT03916874 ·Status: ACTIVE_NOT_RECRUITING
-
Risks of COVID19 in the Pregnant Population
NCT04379284 ·Status: COMPLETED
-
Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19
NCT04718220 ·Status: COMPLETED ·Phase: NA
-
Effects of COVID-19 Infection on Pregnancy Outcomes and Offspring Health
NCT06186947 ·Status: RECRUITING
-
VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination
NCT05570630 ·Status: COMPLETED ·Phase: NA
-
Is the Vaginal Microbiome and Metabolome Associated With Spontaneous Preterm Birth (sPTB) in Multiple Pregnancies?
NCT06053697 ·Status: ACTIVE_NOT_RECRUITING
-
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
NCT05739123 ·Status: RECRUITING
-
The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study
NCT06517628 ·Status: RECRUITING
-
imPROving prenaTal carE During ConfinemenT
NCT04368832 ·Status: COMPLETED
-
Understanding COVID-19 Infection in Pregnant Women and Their Babies
NCT04703270 ·Status: COMPLETED
-
COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY)
NCT04323839 ·Status: COMPLETED
-
Pregnancy and Risk of Venous Thromboembolism
NCT03659708 ·Status: RECRUITING ·Phase: NA
-
Impact of COVID-19 Infection During Pregnancy
NCT05139953 ·Status: COMPLETED
-
Prognostic Impact of Cardiac Imaging During Suspected Immune Checkpoint Inhibitor Myocarditis
NCT05086146 ·Status: UNKNOWN
-
COVID-19 Infection and Fetal-neonatal Outcomes
NCT04699578 ·Status: UNKNOWN
-
What Are the Predictive Factors for Preeclampsia in Oocyte Recipients? - PREROVE
NCT03668184 ·Status: COMPLETED
-
Materno-fetal Consequences of Symptomatic Dengue in Pregnant Wowen in French Guiana
NCT04989673 ·Status: COMPLETED